Rwanda vs United States of America: Treatment success rate for patients treated for MDR-TB
Rwanda
87.0%
in 2022
United States of America
87.0%
in 2021
Rwanda rank
27th
United States of America rank
27th
Treatment success rate for patients treated for MDR-TB over time
- Rwanda
- United States of America
How they compare
Rwanda currently reports 87.0% against 87.0% in United States of America, a difference of 0.0%.
Across all 16 years both countries report, Rwanda has been ahead every year.
Rwanda ranks 27th and United States of America ranks 27th of 163 countries.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Rwanda | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 88.0% | 71.8% | 16.2% | Rwanda |
| 2010s | 89.1% | 74.9% | 14.2% | Rwanda |
| 2020s | 96.0% | 83.5% | 12.5% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Rwanda or United States of America?
- Rwanda, at 87.0% against 87.0% in United States of America as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Rwanda and United States of America?
- 0.0%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and United States of America?
- 16 years are reported by both, from 2006 to 2021.
- How do Rwanda and United States of America rank globally for treatment success rate for patients treated for mdr-tb?
- Rwanda ranks 27th and United States of America ranks 27th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.